Decentralize Research with Flexibility

Right-size how your protocol is decentralized with our flexible, modular digital and DCT platform

Digital Screening:
Recruit Patients at Home

Enable remote screening at scale, globally

Meet your studies enrollment targets faster

Develop any screening assessment

Teleconsent:
Flexible Remote Informed Consent

Improve consent readability with responsive layouts on web, mobile, & more

Deliver remote eConsent to patients on par with consumer digital experiences

Accommodate local regulations and languages with global flexibility

TeleVisit:
Bring on-site experiences home

Engage patients and remove the burden of time and travel of an on-site visit

Improve patient access and engagement

Streamline communication with a safe and compliant Trial-Fit Telemedicine solution

TeleCOA:
Clinical Outcome Assessments Anywhere

Right size your COA strategy

Capture outcome assessments remotely

Deploy diaries, ePROs, and more rapidly

We know now that when patients are able to access a clinical trial online, using telemedicine and remote consent, most clinical trials will enroll three times faster. That’s an incredible data point that we didn’t know before COVID-19.

Dr. Michelle Longmire, CEO of Medable

Remote Patient Monitoring:
DCT Connected Devices

See real-time patient outcome updates

Provide context with quality of life data

Configure intelligent real-time alerts

Trusted by

Why Medable?

1M

Over 1 million patients on platform

>90%

>90% patient app satisfaction

85+

85+ studies across 41+ countries

10-14w

Accelerated Deployment of 10-14 weeks